Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML
Clinical trial NCT02214407 · COMPLETED
Trial details
- NCT number
- NCT02214407
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-14
- Primary completion
- 2021-07-05
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.